Rock Springs Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Sell |
4,465,292
-2,218,955
| -33% | -$6.01M | 0.75% | 47 |
|
|
2025
Q1 | $15M | Sell |
6,684,247
-2,914,923
| -30% | -$6.56M | 0.86% | 43 |
|
|
2024
Q4 | $33.6M | Buy |
9,599,170
+65,000
| +0.7% | +$228K | 1.28% | 29 |
|
|
2024
Q3 | $39.2M | Buy |
9,534,170
+250,678
| +3% | +$1.03M | 1.27% | 29 |
|
|
2024
Q2 | $33.4M | Buy |
9,283,492
+1,141,383
| +14% | +$4.11M | 1.01% | 39 |
|
|
2024
Q1 | $26.9M | Buy |
8,142,109
+158,258
| +2% | +$522K | 0.68% | 51 |
|
|
2023
Q4 | $18.4M | Buy |
7,983,851
+307,370
| +4% | +$710K | 0.45% | 61 |
|
|
2023
Q3 | $9.9M | Buy |
7,676,481
+634,090
| +9% | +$818K | 0.27% | 73 |
|
|
2023
Q2 | $9.3M | Buy |
7,042,391
+797,494
| +13% | +$1.05M | 0.22% | 77 |
|
|
2023
Q1 | $4.41M | Hold |
6,244,897
| – | – | 0.11% | 92 |
|
|
2022
Q4 | $4.68M | Hold |
6,244,897
| – | – | 0.11% | 90 |
|
|
2022
Q3 | $5.38M | Buy |
6,244,897
+14,622
| +0.2% | +$12.6K | 0.14% | 93 |
|
|
2022
Q2 | $6.98M | Buy |
6,230,275
+155,332
| +3% | +$174K | 0.2% | 90 |
|
|
2022
Q1 | $6.8M | Buy |
6,074,943
+489,322
| +9% | +$548K | 0.17% | 96 |
|
|
2021
Q4 | $8.94M | Buy |
5,585,621
+752,643
| +16% | +$1.2M | 0.21% | 96 |
|
|
2021
Q3 | $11.7M | Buy |
4,832,978
+290,209
| +6% | +$702K | 0.25% | 100 |
|
|
2021
Q2 | $14.4M | Buy |
4,542,769
+47,900
| +1% | +$152K | 0.28% | 94 |
|
|
2021
Q1 | $15.1M | Buy |
+4,494,869
| New | +$15.1M | 0.33% | 84 |
|